Navigation Links
Women With Atypia Nearly Eight Times More Likely to Develop Breast Cancer

Washington, June 30 (ANI): A new study has found that women with at least three sites of cellular atypia in breast tissue are nearly eight times more likely than average women to develop breast cancer.

Several earlier studies have shown that atypical hyperplasia (also called atypia) in breast tissue is a major risk factor for breast cancer. Women who have a breast biopsy and are diagnosed with atypia are considered at high risk.

Many are adviced to consider defensive medications such as tamoxifen or other risk-reducing approaches. However, questions remained from previous research on whether a positive family history further increases risk in women with atypia and for how long the increased risk in women with atypia lasts.

The most commonly used tool for risk prediction in women with atypia is the Gail model, which may predict inaccurately because our study shows that family history does not change risk significantly in women with atypia.

Our findings indicate that women with atypia have a higher absolute risk for breast cancer than previously estimated. This risk is 25 percent over 25 years and is much higher in women with multiple areas of atypia and calcification, says Amy Degnim, M.D., a Mayo Clinic surgeon and study author.

The Gail model predicts risk by using age at commencement of menses, age at birth of first child, number of previous breast biopsies, existence of atypia, and number of close relatives with breast cancer.

While the Mayo Clinic study found that family history did not further augment risk, age at diagnosis of atypia did have an effect on risk, with younger women (under age 45) more than twice as likely to develop breast cancer compared to women diagnosed with atypia after 55.

The number of areas of atypical hyperplasia was noteworthy as well. With one area of atypia, breast cancer risk was 2.3-fold compar ed to the general population; this risk more than doubled when two sites were found and augmented to nearly eightfold as sites increased to three or more.

The group of women with the highest risk had three or more areas of atypia and calcification -- with a 10.4-fold risk over the general population.

With the ability to stratify the risk of breast cancer in women with atypia, we can have more informed discussions with our patients regarding their personal risk. This will help us to have individualized discussions regarding how aggressively to pursue risk-reduction treatments, says Dr. Degnim.

These findings resulted from reassessing the records of 331 women with atypia identified within the Mayo group of 9,376 women who had benign breast biopsies surgically obtained between 1967 and 1991.

More than half (55.9 percent) of the women were over age 55 when diagnosed with atypia, and 42.9 percent had a family history of breast cancer. The majority (68.6 percent) of women showed calcification in the biopsy tissue, and 40 percent had multiple sites of atypical hyperplasia.

The current study contributes to Mayos up-and-coming model that seeks to identify every womans risk more accurately and to tailor screening and risk-reduction measures to women depending on their individual risks.


'"/>




Related medicine news :

1. Women suffer from sexual dysfunction too
2. Women find difficulty in calling it Quits
3. Women recognise faces better
4. Women more susceptible to brain damage from ecstasy
5. Good News For Women With Gestational Diabetes
6. Unsatisfactory Grade On Womens Health Issues
7. Risk for Pregnant Women
8. Womens strong sense of smell
9. Women need to exercise more to prevent obesity
10. Women benefit from consuming fish
11. Women are at risk with raised cholesterol
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Living, is proud to recognize Dr. Barry M. Weintraub as a prominent plastic ... most beautiful women in the world, and the most handsome men, look naturally ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: